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Background: Bacterial urinary tract infection (UTI) is a common reason for antimicrobial therapy in dogs.
A reported increase in multi-drug resistance in canine bacterial pathogens, including resistance to extended-
spectrum cephalosporins (ESC) is of concern as antimicrobial resistance complicates therapy in dogs. In addition,
it is a possible public health concern.
The objectives of this study were to investigate the relative prevalence of pathogens in urine samples from dogs
with urinary tract infection sampled at referral hospitals, clinics and mixed veterinary practices and to investigate if
this was influenced by sample material or by contamination of the culture. The second objective was to assess the
susceptibility patterns to clinically relevant antimicrobials and to investigate if this was influenced by whether the
samples originated from smaller clinics or from referral hospitals and to perform active screening for the presence
of Enterobacteriaceae resistant to ESC.
Results: Escherichia coli was the most frequently isolated pathogen (68%) followed by staphylococci (11%).
E. coli isolates were found significantly more often in pure culture than in contaminated samples. Staphylococcus
pseudintermedius and Staphylococcus aureus isolates were significantly more prevalent in pre-incubated samples
compared to samples submitted as non-incubated media.
Susceptibility to the majority of the tested first-line antimicrobials was common. Multiresistance was rare, and these
isolates were all susceptible to at least one relevant antimicrobial. Isolates in samples from small animal clinics or
mixed veterinary practices were less likely to be susceptible compared to isolates originating from referral animal
hospitals. ESC-resistant Enterobacteriacae isolates were found in one per cent of the positive cultures. Bacteria with
transferable ESC resistance were confirmed in one dog. The gene demonstrated was blaCMY2.
Conclusions: Choice of sample material might influence the possibility of detecting Staphylococcus
pseudintermedius and Staphylococcus aureus isolates in clinical cases of UTI in dogs. Based on the study results, use
of first-line antimicrobials is a rational empirical antimicrobial therapy for the studied dog population.
E. coli was the most prevalent pathogen, but prevalence of infection with ESC resistant Enterobacteriaceae
including E. coli was low, as such isolates were found in only one per cent of the positive cultures.
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Bacterial urinary tract infection (UTI) is a common clin-
ical problem in dogs and among the most common reason
for antimicrobial therapy, with approximately 14% of all
dogs having at least one episode of UTI during their
lifetime [1]. An increase in multi-drug resistance in canine
bacterial pathogens, including resistance to extended-
spectrum cephalosporins (ESC) associated with the pro-
duction of extended-spectrum beta-lactamases (ESBL) or
AmpC beta-lactamases, in urinary isolates has been re-
ported [2-6]. Increasing antimicrobial resistance in canine
bacterial pathogens is of concern as it complicates therapy
in dogs. In addition, it is a public health concern when the
pathogens are zoonotic, or the location of the resistance
genes enables transfer between bacteria of animal and hu-
man origin [5,7].
Prudent use of antimicrobials is an important step in re-
ducing the emergence of antimicrobial resistance. Micro-
biological culture combined with susceptibility testing is
the cornerstone of UTI diagnosis and the best instrument
for guiding treatment decisions in individual dogs [8,9].
However, empirical treatment is often necessary before
the culture and susceptibility results are available. In the
context of canine UTIs, prudent use thus includes consid-
ering likely pathogens and their susceptibility patterns
when choosing empirical treatment [8].
The first objective of this study was to estimate the rela-
tive prevalence of uropathogens in dogs with urinary tract
infections and to investigate if this was influenced by sam-
ple material or by contamination of the culture. The sec-
ond objective was to assess the susceptibility patterns to
clinically relevant antimicrobials and to investigate if this
was influenced by whether the samples originated from
smaller veterinary clinics or from referral hospitals and to
perform active screening for the presence of Enterobacte-
riaceae resistant to ESC. The results were intended to aid
in assessing culture results from urinary tract infections in
dogs in clinical practice and to provide a basis for rational
empirical antimicrobial therapy. Moreover, the results




The urine samples were routine samples collected from
dogs with clinical signs of urinary tract infection and
submitted by the attending veterinarian to SVA (National
Veterinary Institute, Sweden) for culture and susceptibility
testing during a ten-month study period (March-December
2009).
Culture
The samples were processed on the day of arrival to SVA.
The referred material (urine sent in a sterile container,bacterial swabs, representative colonies on dipslide, or
agar plate bacterial cultures) were inoculated and spread
onto horse blood agar (National Veterinary Institute,
Uppsala, Sweden) and onto Cysteine Lactose Electrolyte
Deficient agar (Oxoid Ltd, Merck KGaA). All inoculated
agar plates were incubated at 37°C for 24 to 48 h until
adequate growth was present. Bacterial identification
was based on colony type and morphology, gram staining
characteristics and standard biochemical tests [10-12]. In
addition, material from each submitted sample (0.1 mL of
urine or, when the submitted sample consisted of pre-
incubated cultures, the colony material collected by
streaking across the agar using a calibrated loop), was
spread onto MacConkey agar (National Veterinary Insti-
tute, Uppsala, Sweden) supplemented with cefotaxime
(1 mg/L) (Sigma-Aldrich) with the objective to screen for
Enterobacteriaceae resistant to ESC.
After incubation at 37°C for 24 to 48 h until adequate
growth, colonies that based on type and morphology were
identified as possible Escherichia coli, Klebsiella spp. or
Enterobacter spp. were selected and spread on horse-
blood agar (5% v/v) and incubated overnight. To identify
relevant isolates when growth on the selective media was
rich, colonies were spread onto horse-blood agar with a
cefotaxime disc (30 μg, CTO166B Oxoid Ltd) on the agar
surface. The final identification of up to eight representa-
tive isolates per agar plate was based on production of
tryptophanase (indole) and ß-glucuronidase (p-nitrophenyl-
ß-D- glucopyranosiduronic acid, PGUA) and the analytical
profile index API 20 E® identification system (bioMérieux).
Antimicrobial susceptibility
Antimicrobial susceptibility was tested by determination
of minimum inhibitory concentration (MIC) using broth
microdilution following the standards of the Clinical and
Laboratory Standards Institute [13] and using VetMIC
panels (SVA, Uppsala, Sweden). Escherichia coli ATCC
25922 and Enterococcus faecalis ATCC 29212, Staphylo-
coccus aureus ATCC 29213 and Pseudomonas aeruginosa
ATCC 27853 were used for quality control. In addition,
staphylococci were tested for beta-lactamase production
by the “clover-leaf” method as described by Bryan and
Godfrey [14]. Isolates of presumptive uropathogens were
tested for susceptibility to antimicrobials relevant for the
respective bacterial species [15]. Specifically, E. coli, Klebsi-
ella spp. and P. mirabilis were tested for susceptibility to
cefotaxime as an indicator of ESC-resistance, and S. pseu-
dintermedius and S. aureus were tested for susceptibility
to oxacillin as an indicator of methicillin resistance. Iso-
lates were classified as susceptible to an antimicrobial ac-
cording to MIC breakpoints for bacteria from animals
issued by CLSI [16]. CLSI breakpoints for bacteria from
humans were used for nitrofurantoin and cefotaxime as
there are no interpretive criteria for bacteria from animals
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cocci not producing beta-lactamase were classified as sus-
ceptible to ampicillin and penicillin.
An isolate was classified as multiresistant (MDR) if it
was intermediately susceptible or resistant to three or
more antimicrobial classes according to CLSI breakpoints.
For the classification of MDR in E. coli, Klebsiella spp.
and P. mirabilis, ampicillin and amoxicillin-clavulanic
acid were considered one antimicrobial class. For the clas-
sification of staphylococci, streptococci and enterococci,
ampicillin, amoxicillin-clavulanic acid, cephalothin and
penicillin were considered one antimicrobial class. Antimi-
crobials to which a bacterial species has inherently low
susceptibility were not included in the classification of
MDR. This applies to ampicillin and nitrofurantoin in
Klebsiella spp., nitrofurantoin and tetracycline in P.
mirabilis and to enrofloxacin and gentamicin in strepto-
cocci. Enterococci have constitutively low susceptibility to
several of the antimicrobials studied, and only ampicillin,
tetracycline, trimethoprim-sulphametoxazole and nitro-
furantoin were considered in the evaluation of MDR in
enterococci.
Isolates of E. coli, Klebsiella spp. and Enterobacter spp. re-
covered from the screening for ESC-resistance were tested
for susceptibility to cefotaxime by broth microdilution as
described above. Isolates with cefotaxime MIC >1 mg/L
were further analysed for the production of ESBL or AmpC
by the double disc diffusion test according to CLSI [13].
Genotyping
Presumptive methicillin resistant staphylococci, based
on oxacillin MIC, were tested for presence of the mecA
gene by PCR as described by Strommenger et al. [18].
To differentiate isolates of Enterobacteriaceae with
chromosomal AmpC production from isolates carrying
plasmidic AmpC, a multiplex PCR assay for the plasmid
carrying the beta-lactamase families MOX, CIT, DHA,
ACC, EBC and FOX was used [19]. In isolates shown to
carry plasmidic AmpC, the gene variants were deter-
mined by sequencing using in-house primers (blacmy-2
5′- AAATCGTTATGCTSCGCTCT and 5′- CATGG
GATTTTCCTTGCTGT) and Big-Dye™ v1.1.
Statistical analyses
The statistical analyses were performed using Stata Soft-
ware (StataCorp. 2012; Stata Statistical Software: Release
11.2; College Station, TX, USA: StataCorpLP). Descrip-
tive statistics were used to describe the uropathogens
isolated in pure and contaminated culture, in different
sample media (pre-incubated cultures or non-incubated
samples), and from different submission categories. Uni-
variable associations between findings of the isolated
uropathogens and the three explanatory variables; sub-
mission category, sample media (whether the sampleswere sent in as pre-incubated cultures or not), and if the
samples were in pure or contaminated cultures were in-
vestigated using Fisher’s exact-test, the χ2-test and uni-
variable logistic regression analysis. The same tests were
used for investigation of aassociations between submis-
sion category and if samples were in pure or contaminated
culture, as well as for associations between submission
category and the use of different sample media. The same
univariable tests were used to investigate if antimicrobial
susceptibility in isolates varied by submission category.
Moreover, for every uropathogen a multivariable logistic
regression analysis was performed using a manual step-
wise backward variable selection procedure in where the
initial models included all three explanatory variables as
main effects. Collinearity between the explanatory vari-
ables was assessed pair-wise by Spearman rank correla-
tions. If there was proof of collinearity (r ≥ 0.70) the
variable with lowest P-value in the univariable analysis was
selected. All plausible two-way interactions between the
significant main effects were tested. Variables with a sig-
nificant association (P < 0.05) with the dependent variable
were kept in the model. The model fit was evaluated with
the Hosmer-Lemeshow goodness-of-fit test and by visual
examination of diagnostic plots as outlined by Hosmer
and Lemeshow [20]. For all the analyses performed, the
level of statistical significance was set at P ≤0.05.
Ethics
All samples were collected during routine diagnostics. The
study was approved by the Swedish Board of Agriculture




Of the in total 1042 submitted samples, 469 (45%) origi-
nated from four small animal referral hospitals that sub-
mitted 94–129 samples each. Approximately a quarter of
the samples (n = 277; 27%) were referred by ten separate
small animal clinics, each contributing 11–55 samples.
The remaining 296 samples (28%) were from 115 mixed
veterinary practices, of which none submitted more than
ten urinary samples. These three submission categories;
small animal referral hospitals, small animal clinics and
mixed veterinary practices were labelled A, B and C, re-
spectively (Table 1).
Characterisation of bacterial growth
Of the submitted samples, 961 were found to be from
individual dogs. A specific urinary pathogen was isolated
in 623 (65%) of these. Culture of 338 samples (35%)
yielded either no bacterial growth or only insignificant
non-specific growth of contaminants, including 20 sam-
ples where more than one possible pathogen was found
Table 1 Findings of uropathogens in submitted urinary samples presented by submission category, sample material
and growth
Submission category Sample material Growth
A B C Pre-incubated Non-incubated Pure Conta-minated
% (n) % (n) % (n) % (n) % (n) % (n) % (n)
Positive cultures individual dogs (n = 623) 45 (284) 25 (154) 30 (185) 68 (423) 32 (200) 60 (375) 40 (248)
Positive cultures repeated samples (n = 48) 52 (25) 33 (16) 13 (7) 83 (40) 17 (8) 58 (28) 42 (20)
Samples without significant growth (n = 371) 43 (160) 29 (107) 28 (104) 26 (95) 74 (276) 0 0
The relative prevalence (%) is presented with the number of samples shown inside brackets.
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further confirmation of the suspected findings (Table 1).
Eighty-one of the submitted samples were found to be
repeated samples from dogs already included in the
study. Of these, 48 positive cultures were found to be re-
peated samples from 40 dogs, and 33 samples yielded no
growth or only non-specific growth. The 48 repeated
samples with positive cultures were evaluated separately.
Significantly more pre-incubated (68%, n = 423) than
non-incubated samples (32%, n = 200) yielded positive
culture results (P < 0-001). Samples that were incubatedTable 2 Relative prevalence of uropathogens in non-repeated
Submission category A referral





Pre-incubated 87%, (n = 248)
Pure growth, (n = 174) 72 (131) 57 (16) 77 (10)
Contaminated growth, (n = 74) 28 (50) 43 (12) 23 (3)
Non-incubated, 13% (n = 36)
Pure growth, (n = 22) 74 (17) 50 (2) 25 (1)
Contaminated growth, (n = 14) 26 (6) 50 (2) 75 (3)
Submission category B small





Pre-incubated, 56%, (n = 87)
Pure growth, (n = 53) 68 (42) 67 (6) 33 (3)
Contaminated growth, (n = 34) 32 (20) 33 (3) 67 (6)
Non-incubated, 44%, (n = 67)
Pure growth, (n = 34) 52 (25) 67 (2) 75 (6)
Contaminated growth, (n = 33) 48 (23) 33 (1) 25 (2)
Submission category C mixed





Pre-incubated, 48%, (n = 88)
Pure growth, (n = 45) 52 (29) 50 (6) 67 (6)
Contaminated growth, (n = 43) 48 (27) 50 (6) 33 (3)
Non-incubated, 52%, (n = 97)
Pure growth, (n = 47) 51 (30) 50 (2) 50 (6)
Contaminated growth, (n = 50) 49 (29) 50 (2) 50 (6)
Total 68 (429) 10 (60) 9 (55)
The relative prevalence (%) is presented by the three submission categories; small a
labelled A, B and C, respectively, as well as by submitted sample material and by puprior to referral were six times more likely to yield posi-
tive growth.Positive cultures from individual dogs
Seven different urinary pathogens were identified in the
623 positive cultures with a specific urinary pathogen.
Escherichia coli was the most prevalent, being identified in
429 (68.9%) of the samples, followed by S. pseudintermedius
(9.6%, n = 60), P. mirabilis (8.8%, n = 55), beta haemolytic








78 (7) 57 (4) 71 (5) 33 (1)
22 (2) 43 (3) 29 (2) 67 (2)
50 (2) - 0 (0) -








0 (0) 0 (0) 100 (2) 0 (0)
100 (2) 100 (1) 0 (0) 100 (2)
0 (0) - 33 (1) -








25 (1) 100 (2) 33 (1) 0 (0)
75 (3) 0 (0) 67 (2) 100 (2)
36 (4) - 43 (3) 50 (2)
64 (7) - 57 (4) 50 (2)
5 (35) 2 (10) 4 (23) 2 (11)
nimal referral hospitals, small animal clinics and mixed veterinary practices are
re- or contaminated growth. The number of samples is shown inside brackets.
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n =10) (Table 2).
Forty-six per cent (n = 284) of the 623 cultures with a
specific urinary pathogen originated from submission cat-
egory A, 25% (n = 154) from category B and 30% (n =185)
from category C. Approximately 68% (n = 423) of the sam-
ples were submitted to the laboratory as pre-incubated
cultures on dipslides (42%) or agar plates (26%). The 200
non-incubated samples were submitted in the form of
urine collected in a sterile container (19%) or as bacterial
swabs dipped in urine (13%). Submission category A sent
in more samples using pre-incubated sample media than
submission groups B and C (P < 0.001 and P < 0.001,
respectively).
Of the 623 samples, 60% (n = 375) were in pure growth,
and 40% (n = 248) were in contaminated growth (Table 1).
Significantly more samples from submission category A
were in pure culture compared to submission categories
B (P < 0.01) and C (P < 0.001). Significantly more pre-
incubated than non-incubated samples were in pure culture
(P < 0.01) compared to contaminated culture. No significant
differences were observed between the pre-incubated or
non-incubated samples and the pure or contaminated sam-
ples when submission category was considered (Table 2).
The results of the multivariable logistic regression ana-
lyses of associations between the bacterial findings and
the explanatory variables (submission category, submit-
ted sample media and whether the samples were con-
taminated) differed between the uropathogens. The only
multivariable model where more than one explanatory
variable was significantly associated with the analysed
uropathogen was the model of association with findings
of beta haemolytic Streptococcus spp. Hence, the results
for all other uropathogens are from the univariable logis-
tic regression analyses.
There was a higher probability of finding S. pseudinter-
medius in pre-incubated sample media (n = 49) compared
to non-incubated sample media (OR = 2.2; P = 0.019; n =
20). The use of pre-incubated sample media was associ-
ated with a lower probability of finding beta haemolytic
Streptococcus spp. (OR = 0.4; P = 0.004; n = 15) compared
to non-incubated sample media (n = 20). The ten S. aureus
isolates were all found in pre-incubated samples. The
probability of finding E. coli was lower (OR = 0.6; P =
0.005) in contaminated cultures (n = 155) than in pure
cultures (n = 274), while the probability of finding beta
haemolytic Streptococcus spp. (OR = 2.1; P = 0.04; n = 21)
or Klebsiella spp. (OR = 4.1; P = 0.04 n = 8) was higher in
contaminated cultures compared to pure cultures (n = 14
and n = 3, respectively).
Positive cultures from repeated samples
The same pathogen was isolated on both occasions in all
48 repeated sample occasions with positive culture results.The bacteria isolated were E. coli (81.2%, n = 39), S. pseu-
dintermedius (6.3%, n = 3), P. mirabilis (6.3%, n = 3)%,
Klebsiella spp. (4.2%, n = 2)%), and Enterococcus spp.
(2.0%, n = 1).
All but four samples were submitted by the same vet-
erinary practice, clinic or hospital that sampled the dog
the first time. Approximately half of the samples (52%,
n = 25) originated from category A, one third (33%, n =
16) were from category B and 14% (n = 7) were from cat-
egory C. For all but two dogs, the submitted sample ma-
terial did not differ between the sample occasions, and
83% (n = 40) of the samples were submitted as pre-
incubated cultures.
Antimicrobial susceptibility patterns in positive cultures
from individual dogs
Of the gram-negative pathogens, E. coli had the overall
highest percentage of susceptibility (Table 3). Most (79%)
E. coli isolates were susceptible to all the tested antimicro-
bials. Susceptibility to the individual antimicrobials varied
between 87 and approximately 100%, with reduced sus-
ceptibility to aminopenicillins (ampicillin and amoxicillin-
clavulanic acid) being the most common trait (Table 3).
Seventeen E. coli isolates (4%) were multiresistant (Table 4).
Eleven of these isolates were susceptible both to first gener-
ation fluoroquinolones (enrofloxacin) and nitrofurantoin.
The remaining six multiresistant isolates were suscep-
tible to at least one antimicrobial, which was usually
nitrofurantoin.
The majority (73 to 95%) of Klebsiella spp. and
P. mirabilis isolates were susceptible to amoxicillin-
clavulanic acid, gentamicin, enrofloxacin and trimethoprim-
sulfamethoxazole. Ninety-one per cent of P. mirabilis
isolates were susceptible to ampicillin. Constitutive resist-
ance was reflected in the low number of isolates being sus-
ceptible to nitrofurantoin in both species (27% and 9%,
respectively), in susceptibility to tetracycline being ob-
served in less than 6% of the P. mirabilis isolates, and by
none of the Klebsiella spp. isolates being susceptible to
ampicillin (Table 3). No Klebsiella spp. isolates were sus-
ceptible to ampicillin. Disregarding constitutive resistance,
no Klebsiella spp. isolates were multiresistant, although
one isolate was neither susceptible to gentamicin nor to
trimethoprim-sulphametoxazole. Only one P. mirabilis
isolate (2%) was multiresistant when constitutive resist-
ance to tetracycline and nitrofurantoin was disregarded.
The isolate was not susceptible to ampicillin, gentamicin
or trimethoprim-sulphametoxazole. A reduced susceptibil-
ity to cefotaxime, MIC >1 mg/L was detected in one iso-
late each of E. coli and P. mirabilis. Both of these isolates
produced AmpC beta-lactamase. Further testing for the
genotype was not performed.
The screening for isolates with ESC-resistance by cul-
ture on cefotaxime supplemented media yielded growth
Table 3 Antimicrobial susceptibility (%) of E. coli, Klebsiella spp. and P. mirabilis in non-repeated samples
Antimicrobial Breakpoint
S
Escherichia coli Klebsiella spp. Proteus mirabilis
All A B C All A B C All A B C
(mg/L) (429) (204) (110) (115) (11) (3) (2) (69 (55) (17) (17) (21)
Ampicillin ≤ 8 87.9 91.2 85.5 84.3 0.0 0.0 0.0 0.0 90.9 88.2 94.1 90.5
Amoxicillin/Clavulanic acid ≤ 8 87.2 89.7 85.5 84.3 72.7 66.7 100 66.7 94.5 100 94.1 90.5
Cefotaxime ≤ 1 99.8 99.5 100 100 100 100 100 100 98.2 100 94.1 100
Gentamicin ≤ 2 94.9 95.1 93.6 95.7 90.9 100 100 83.3 83.6 82.4 82.4 85.7
Enrofloxacin ≤ 0.5 97.9 98.5 95.5 99.1 90.9 100 100 83.3 96.4 100 88.2 100
Tetracycline ≤ 4 92.1 95.1 90.0 88.7 100 100 100 100 5.5 5.9 5.9 4.8
Trimethoprim/Sulphametoxazole ≤ 2/38 92.3 96.6 89.1 87.8 90.9 100 100 83.3 89.1 88.2 88.2 90.5
Nitrofurantoin ≤ 32 98.4 99.5 98.2 96.5 27.3 33.3 50.0 16.7 9.1 5.9 11.8 9.5
Breakpoints for susceptibility (BP S) (mg/L) are indicated. The number of samples is shown inside brackets. The three submission categories; small animal referral
hospitals, small animal clinics and mixed veterinary practices are labelled A, B and C, respectively.
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Enterobacter aerogenes (two samples each). All seven
isolates had cefotaxime MIC ≥ 2 mg/L and were con-
firmed as AmpC producers by phenotypic tests. A plas-
midic AmpC gene was confirmed in only one isolate,
which was an E. coli isolate carrying a gene of the CIT
group that was confirmed as blacmy-2 by sequencing.
This isolate was obtained from the same sample as the
E. coli isolate described above with reduced susceptibility
to cefotaxime found on non-selective culture.
Only 10% of S. pseudintermedius and S. aureus isolates
were susceptible to penicillin and ampicillin; 90% were re-
sistant by production of beta-lactamase. Susceptibility to
other antimicrobials ranged from 87 to 100%, with the ex-
ception of tetracycline, to which about 65% of the isolates
were susceptible (Table 5). One S. pseudintermedius isolate
had oxacillin MIC >2 mg/L and was confirmed as a mecA
carrier. None of the S. aureus isolates but six isolates of
S. pseudintermedius (10%) were multiresistant, including
the methicillin resistant isolate (Table 6). Beta-haemolytic
streptococci were uniformly susceptible to penicillin,
amoxicillin-clavulanic acid, trimethoprim-sulphametoxazole
and nitrofurantoin. The proportion of isolates susceptible to
tetracycline or enrofloxacin was lower, 64% and 15%, re-
spectively (Table 5). No isolate was multiresistant. Entero-
cocci were the least susceptible of the isolated pathogens if
all tested antimicrobials are considered (Table 5). However,
susceptibility to ampicillin, amoxicillin-clavulanic acid,Table 4 Resistance phenotypes of the 17 multidrugresistant E
Number of isolates Ampicillin Gentamicin Enrofloxacin
3 R R R




The letter “R” in bold indicates resistance.trimethoprim-sulphametoxazole and nitrofurantoin was
high, with more than 80% of all the isolates being sus-
ceptible. Two isolates (9%) were resistant to three or
more of these antimicrobials (Table 5).
Comparison of susceptibility patterns between the three
submission categories showed that the probability of find-
ing trimethoprim-sulphametoxazole resistant E. coli was
higher for submission categories B and C compared to sub-
mission group A (OR = 3.4; P = 0.01 and OR= 3.9; P =
0.004, respectively). The probability of finding tetracycline
resistant E. coli was higher (OR = 2.5; P = 0.04) for submis-
sion category C than for submission category A. Escherichia
coli from submission category C were more likely to be
multiresistant than isolates from category A (OR= 2.7; P =
0.02). There was a trend for isolates from category B to be
multiresistant to a greater extent than isolates from
category A, but the difference was not significant (OR = 2.4;
P = 0.052). There were no associations between submission
category and antimicrobial susceptibility of P. mirabilis or
beta-haemolytic streptococci, and the small number of re-
sistant isolates precluded a statistical assessment of such as-
sociations for S. pseudintermedius, S. aureus, Klebsiella spp.
or Enterococcus spp.
Antimicrobial susceptibility patterns in positive cultures
from repeated samples
Eighty-three per cent (n = 32) of the 39 E. coli isolates in







Table 5 Antimicrobial susceptibility (%) of S. pseudintermedius, S. aureus, beta haemolytic streptococci and enterococci
in non-repeated samples
Antimicrobial Staphylococcus pseudintermedius Staphylococcus aureus Beta-hemolytic streptococci Enterococci
(n = 60) (n = 10) (n = 33) (n = 55)
BP S % S BP S % S BP S % S BP S % S
Penicillin β-lacta 10.0 β-lact 30.0 ≤ 0.12 100 ≤ 8 NR
Ampicillin β-lact 10.0 β-lact 30.0 ≤ 0.25 NR ≤ 8 87.0
Amoxicillin/Clavulanic acid ≤ 8 96.7 ≤ 8 100 ≤ 8 100 ≤ 8 82.6
Cephalothin ≤ 2 98.3 ≤ 2 100 ≤ 2 100 ≤ 2 13.0
Oxacillin ≤ 0.25 NRb ≤ 2 100 - - - -
Gentamicin ≤ 2 98.3 ≤ 2 100 ≤ 2 0.0 ≤ 2 30.4
Erythromycin ≤ 0.5 86.7 ≤ 0.5 100 ≤ 0.25 NR ≤ 0.5 34.8
Enrofloxacin ≤ 0.5 98.3 ≤ 0.5 100 ≤ 0.5 15.2 ≤ 0.5 47.8
Tetracycline ≤ 4 66.7 ≤ 4 90.0 ≤ 2 63.6 ≤ 4 65.2
Trimethoprim/Sulphametoxazole ≤ 2/38 95.0 ≤ 2/38 100 ≤ 2/38 100 ≤ 2/38 87.0
Nitrofurantoin ≤ 32 100 ≤ 32 100 ≤ 32 100 ≤ 32 82.6
Breakpoints for susceptibility (BP S) (mg/L) are indicated. The number of samples is shown inside brackets. Results from the susceptibility testing of one
beta-haemolytic streptococcus isolate were lost and are not presented.
aβ-lact = beta-lactamase production.
bNR = not relevant since the BP is outside of the range of concentrations tested.
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yielding E. coli isolates with resistance traits, the isolates
were less susceptible than on the first sample occasion.
Four isolates were multiresistant (10% of the 39 E. coli
isolates). Multiresistance was already present in the first
isolates from the three dogs involved, but the isolates
from the repeated samples had additional resistance to
trimethoprim-sulphametoxazole. No Enterobacteriaceae
resistant to ESC were isolated.
In eight of the nine dogs where bacteria other than E.
coli were found, all isolates were susceptible to all anti-
microbials tested on all sample occasions. In one dog, S.
pseudintermedius susceptible to penicillin was isolated
from the first and penicillin resistant S. pseudintermedius
from the second sample occasion.
Discussion
The seven urinary pathogens isolated in this study are
the bacterial pathogens most frequently associated with
UTI in dogs [21-23]. In accordance with previous re-
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To avoid false-positive and false-negative results im-
mediate culture after collection of a urine specimen is
recommended. If this is not possible, the samples should
ideally be refrigerated within 1 or 2 hours of collection
[27,28]. In a practice setting urine is however often re-
ferred to an external laboratory for confirmation and
identification of specific bacterial organisms [27,29]. Fur-
thermore, it is not uncommon for both cystocentesis
and second-best options in trying to avoid bacterial con-
tamination of the sample, like catheterization or secur-
ing a midstream sample, to be unrealistic alternatives
when colleting the sample due to either cost or practical
problems in handling of the individual dog. The possible
influence on the results of collection method and hand-
ling of the samples in the present study could not be
fully evaluated as the collection methods were unknown,
but prevalence of growth of the individual bacterial spe-
cies was compared between the two categories pure and
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This indicates that the relatively high prevalence of E.
coli in the material was not due to misinterpretation of
faecal or genital contamination of samples.
The finding that samples submitted to the laboratory as
pre-incubated agar plates or dipslide cultures yielded sig-
nificantly more positive culture results than non-incubated
urinary samples might be explained by attending veterinar-
ians choosing not to submit agar-plates until growth of
suspected pathogens is evident. Choice of material was not
shown to be a major factor influencing the relative preva-
lence of bacterial species among the positive cultures, with
the exception of staphylococci, which were found more
often in pre-incubated sample media. Ling et al. [24] re-
ported that Proteus spp. were isolated more frequently
from urine specimens collected by catheterization or
midstream catch than by cystocentesis, but to what ex-
tent the prevalence of various bacterial agents is influ-
enced by sample technique and sample material is
otherwise not well described. Further studies specifically
designed to compare sample methods and sample mate-
rials are warranted.
In the present study, there was a possibility of more
than one pathogen causing the UTI in two per cent of
all the positive samples. This is in accordance with pre-
vious studies showing that more than 70% of UTIs in
dogs are caused by a single pathogen [8,24,29]. None of
the samples with multiple pathogens originated from the
45 dogs that were sampled repeatedly. This is in contrast
to previous studies, where an association between a
higher prevalence of multiple organisms and recurrent
and persistent UTIs has been reported [21,31].
Antimicrobial susceptibility of E. coli from UTIs in dogs
in Sweden has previously been reported from samples col-
lected in 1991–92 and in 2002–03 [32]. If our data are re-
evaluated by the cut-off values used by Hagman & Greko,
the proportions of susceptible isolates in the two studies
are similar [32]. Resistance in E. coli collected from UTIs
in dogs in Sweden is apparently stable or improving,
which is supported by national surveillance data showing
that susceptibility to relevant antimicrobials has re-
mained stable for the last two decades [33]. The situ-
ation is favourable in comparison to studies from other
countries, where the proportion of susceptible E. coli is
smaller [30,34,35].
Susceptibility among Klebsiella spp. or Proteus mirabilis
was high compared to previously reported data [34]. There
were several appropriate first line antimicrobials available
for treatment in the approximately ten per cent of UTIs
caused by either of these two species. The constitutive re-
sistance to nitrofurantoin in both species, to ampicillin
and amoxicillin in Klebsiella spp. and to tetracycline in
Proteus mirabilis is reflected in this study as well as in pre-
vious reports [34,36].Among the gram-positive isolates, susceptibility to
penicillin and aminopenicillins was uncommon in
staphylococci, while all streptococci were susceptible to
these antimicrobials. In staphylococci, the second most
common cause of UTI, susceptibility to other anti-
microbials was high, ranging between 67 and 100%,
including 97% of the isolates being susceptible to
amoxicillin-clavulanic acid. Our findings agree with
previous reports [26,34] and with data regarding the
susceptibility of staphylococci and streptococci from
dogs in Sweden reported in the monitoring program
SWEDRES-SVARM [33]. The inherently low suscepti-
bility of streptococci and enterococci to enrofloxacin
that was demonstrated in this study has also been
observed by others [34,36]. Several relevant treatment
options were thus available when the UTI was caused
by a gram-positive pathogen, including the 4% of UTIs
caused by enterococci, which was the pathogen with
the overall least favourable susceptibility pattern.
Many previous reports on growth of pathogens and
antimicrobial susceptibility patterns in urinary tract in-
fections in dogs are based on samples collected at refer-
ral animal hospitals based at universities in various
countries. The samples included in the present study
were from a wide range of veterinary practices with a
geographical spread over the country and with both pri-
mary care facilities and referral animal hospitals repre-
sented, making the material representative of the actual
population in the country. Interestingly, the probability
of finding less susceptible isolates in our study was sig-
nificantly higher in samples originating from small ani-
mal clinics or mixed veterinary practices than in samples
from referral animal hospitals. The only exception to
this was amoxicillin-clavulanic resistance in the limited
number of Enterococcus spp. isolates. It has previously
been stated that, as referral hospitals are more likely to
have a higher caseload of complicated and recurrent
cases, less susceptible isolates should be expected in
samples originating from referral animal hospitals com-
pared to smaller clinics [24,25,32].
In accordance with previous studies, E. coli was the most
common pathogen in the repeated samples [8,21,22]. The
national guidelines states that culture and antimicrobial
susceptibility testing always is to be performed when UTI
is suspected in a dog, the only possible exception being
uncomplicated first-time UTIs in young bitches (http://
www.smadjurssektionen.se/start/policys-och-guidelines). It
is still possible that more dogs had been diagnosed with
UTI previously, as other veterinary care facilities in the
country do not routinely submit their samples for cultures
to SVA. However, the low percentage of recurrent or per-
sistent UTIs correlates with previous reports that con-
cluded that the majority of UTIs in dogs are uncomplicated
and occur as single episodes [8,21,22].
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mon in the repeatedly sampled 40 dogs compared to the
dogs that were only sampled once. These findings sup-
port the need for culture and susceptibility testing and
the need for investigating the possible underlying causes
in dogs with recurrent or persistent UTI. However, to
presume that the cause of a recurrent or persistent UTI
is a resistant uropathogen needing combination therapy
with broad-spectrum antimicrobials would be incorrect
in more than 80% of the cases in the present study.
Phenotypic resistance to ESC in Enterobacteriaceae
was rare. A similarly low ESC resistance in E. coli from
dogs in Sweden was reported during 2010 – 2012 in
SVARM, where approximately 1% of E. coli from UTIs
in dogs had reduced susceptibility to cefotaxime (MIC >
1 mg/L) [33]. Higher prevalence of ESC resistant E. coli
from various infections sites in dogs has been reported
from other countries [4,34,37] and transmissible genes
coding ESC resistance known to be common in isolates
from humans have been found in bacteria isolated from
pet animals [4,38,39]. In the present study, the only
transmissible gene demonstrated was blaCMY2, which in
a contemporary study was found in only a small propor-
tion of ESC resistant E. coli from humans in Sweden
[33]. This scenario might change if ESC resistance be-
comes common in dogs, and vigilance towards ESC re-
sistance in animal healthcare is warranted.
Conclusions
E. coli was the most frequent pathogen identified in the
study followed by staphylococci. E. coli was found more
often in pure culture than in contaminated samples. Choice
of sample material might influence the possibility of detect-
ing Staphylococcus pseudintermedius and Staphylococcus
aureus isolates in clinical cases of UTI in dogs, as S. pseu-
dintermedius and S. aureus were more prevalent in samples
submitted to the laboratory as pre-incubated sample media
compared to samples submitted as non-incubated media.
The results of the susceptibility testing were favourable
and use of only first-line antimicrobials is based on the
study results a rational empirical antimicrobial therapy
for the studied dog population. Disregarding constitutive
resistance, susceptibility to the majority of the tested
first line antimicrobials was common. Multiresistance
was rare, and such isolates were all susceptible to at least
one antimicrobial relevant for the species and for the
treatment of UTI. Isolates were less susceptible in sam-
ples originating from small animal clinics or mixed vet-
erinary practices compared to the samples from referral
animal hospitals.
Phenotypic resistance to ESC in Enterobacteriaceae
was found in one per cent of all positive cultures. Bac-
teria with transferable ESC resistance were confirmed in
only one dog. The gene demonstrated was blaCMY2.Competing interests
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